Hait W N, Pierson N R
Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06510.
Cancer Res. 1990 Feb 15;50(4):1165-9.
Dequalinium belongs to a group of cationic lipophilic drugs believed to be selectively cytotoxic to malignant cells of epithelial origin by virtue of their accumulation in mitochondria. In addition, they are potent inhibitors of calmodulin and, therefore, might sensitize multidrug-resistant cells to chemotherapeutic agents. We compared the responsiveness of multidrug-resistant cells to the effect of dequalinium with that to trifluoperazine, a potent phenothiazine inhibitor of calmodulin. In addition, we studied the effect of these drugs on the responsiveness of multidrug-resistant cell lines to doxorubicin. The effect of drugs on P388 murine leukemic cells was determined by cell counting, [3H]thymidine incorporation into DNA, or soft agar cloning. Drug accumulation was measured by fluorescence spectrophotometry. We found that multidrug-resistant lines were less sensitive than parental cell lines to the intrinsic growth inhibitory effects of dequalinium (IC50, 4.4 versus 0.3 microM in multidrug-resistant and sensitive P388 cells, respectively), whereas they were equally sensitive as the parental line to the effects of trifluoperazine. Following a 3-h exposure of P388/doxorubicin-resistant cells to 0-100 microM doxorubicin with or without either 10 microM dequalinium or 10 microM trifluoperazine, the latter increased the sensitivity to doxorubicin whereas the former had little effect (IC50 values were doxorubicin, 30 microM; doxorubicin plus dequalinium, 25 microM; doxorubicin plus trifluoperazine, 4 microM). Calmodulin prepared from resistant cells were equally sensitive to inhibition by dequalinium and trifluoperazine. P388/doxorubicin-resistant cells accumulated 4.5-fold less dequalinium than P388 cells whereas trifluoperazine was accumulated equally in both. The addition of 4 microM trifluoperazine to resistant cells exposed to 0-100 microM dequalinium completely reversed the alteration in accumulation and resistance to the dequalinium. These studies demonstrate that certain multidrug-resistant lines are cross-resistant to dequalinium and that sensitivity can be completely restored by nontoxic concentrations of trifluoperazine. The resistance appears to be due to changes in drug accumulation and not to be related to an altered sensitivity of calmodulin.
地喹氯铵属于一类阳离子亲脂性药物,据信由于其在线粒体中的蓄积而对上皮来源的恶性细胞具有选择性细胞毒性。此外,它们是钙调蛋白的强效抑制剂,因此可能使多药耐药细胞对化疗药物敏感。我们比较了多药耐药细胞对地喹氯铵与三氟拉嗪(一种强效的钙调蛋白吩噻嗪抑制剂)作用的反应性。此外,我们研究了这些药物对多药耐药细胞系对阿霉素反应性的影响。通过细胞计数、[3H]胸苷掺入DNA或软琼脂克隆来测定药物对P388小鼠白血病细胞的作用。通过荧光分光光度法测量药物蓄积。我们发现,多药耐药细胞系比亲代细胞系对地喹氯铵的内在生长抑制作用更不敏感(在多药耐药和敏感的P388细胞中,IC50分别为4.4和0.3 microM),而它们对三氟拉嗪的作用与亲代细胞系同样敏感。将P388/阿霉素耐药细胞暴露于0 - 100 microM阿霉素3小时,同时加入或不加入10 microM地喹氯铵或10 microM三氟拉嗪,结果显示后者增加了对阿霉素的敏感性,而前者几乎没有作用(IC50值分别为:阿霉素,30 microM;阿霉素加地喹氯铵,25 microM;阿霉素加三氟拉嗪,4 microM)。从耐药细胞中制备的钙调蛋白对地喹氯铵和三氟拉嗪的抑制同样敏感。P388/阿霉素耐药细胞对地喹氯铵的蓄积比P388细胞少4.5倍,而三氟拉嗪在两者中的蓄积相同。向暴露于0 - 100 microM地喹氯铵 的耐药细胞中加入4 microM三氟拉嗪,完全逆转了地喹氯铵蓄积和耐药性的改变。这些研究表明,某些多药耐药细胞系对地喹氯铵存在交叉耐药性,并且无毒浓度的三氟拉嗪可以完全恢复其敏感性。耐药性似乎是由于药物蓄积的变化,而与钙调蛋白敏感性的改变无关。